Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

367 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New insights into the antiviral effects of chloroquine.
Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. Savarino A, et al. Lancet Infect Dis. 2006 Feb;6(2):67-9. doi: 10.1016/S1473-3099(06)70361-9. Lancet Infect Dis. 2006. PMID: 16439323 Free PMC article. No abstract available.
On the use of chloroquine for chikungunya.
Savarino A, Cauda R, Cassone A. Savarino A, et al. Lancet Infect Dis. 2007 Oct;7(10):633. doi: 10.1016/S1473-3099(07)70217-7. Lancet Infect Dis. 2007. PMID: 17897603 Free PMC article. No abstract available.
Effects of chloroquine on viral infections: an old drug against today's diseases?
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Savarino A, et al. Lancet Infect Dis. 2003 Nov;3(11):722-7. doi: 10.1016/s1473-3099(03)00806-5. Lancet Infect Dis. 2003. PMID: 14592603 Free PMC article. Review.
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral infections. ...We review the available information on the effects of chloroquine on …
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemi …
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects.
Cassone A, Tacconelli E, De Bernardis F, Tumbarello M, Torosantucci A, Chiani P, Cauda R. Cassone A, et al. J Infect Dis. 2002 Jan 15;185(2):188-95. doi: 10.1086/338445. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807692
Highly active antiretroviral therapies (HAARTs) that contain human immunodeficiency virus (HIV) protease inhibitors (PIs) or nonnucleoside reverse-transcriptase inhibitors (NNRTIs) were compared for their effect on secretory aspartyl proteinase (Sap), a virulence trait for …
Highly active antiretroviral therapies (HAARTs) that contain human immunodeficiency virus (HIV) protease inhibitors (PIs) or nonnucleoside r …
In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.
Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. Cassone A, et al. J Infect Dis. 1999 Aug;180(2):448-53. doi: 10.1086/314871. J Infect Dis. 1999. PMID: 10395861
The effect of two PIs (indinavir and ritonavir) on the enzymatic activity of a secretory aspartyl protease (Sap) of Candida albicans (a major agent of mucosal disease in HIV-infected subjects) and on growth and experimental pathogenicity of this fungus was evaluated …
The effect of two PIs (indinavir and ritonavir) on the enzymatic activity of a secretory aspartyl protease (Sap) of Candida albicans …
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons.
Carlesimo M, Pontesilli O, Guerra EC, Varani AR, Bernardi ML, Ricci G, Alario C, Pirillo MF, Mattiacci G, Leone P, Cassone A, Aiuti F. Carlesimo M, et al. J Infect Dis. 1997 Oct;176(4):904-12. doi: 10.1086/516500. J Infect Dis. 1997. PMID: 9333148 Clinical Trial.
Cellular immune responses to human immunodeficiency virus type 1 (HIV-1) antigens, microbial recall antigens, and CD3 monoclonal antibody were studied in HIV-1-infected asymptomatic patients in a phase II, double-blind trial of immunization with recombinant HIV-1 gp160 in …
Cellular immune responses to human immunodeficiency virus type 1 (HIV-1) antigens, microbial recall antigens, and CD3 monoclonal antibody we …
Infection with chikungunya virus in Italy: an outbreak in a temperate region.
Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A; CHIKV study group. Rezza G, et al. Lancet. 2007 Dec 1;370(9602):1840-6. doi: 10.1016/S0140-6736(07)61779-6. Lancet. 2007. PMID: 18061059
The presumed index case was a man from India who developed symptoms while visiting relatives in one of the villages. Phylogenetic analysis showed a high similarity between the strains found in Italy and those identified during an earlier outbreak on islands in the I …
The presumed index case was a man from India who developed symptoms while visiting relatives in one of the villages. Phylogenetic ana …
An outbreak of chikungunya fever in the province of Ravenna, Italy.
Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Macini P, Fiorentini C, Fortuna C, Venturi G, Romi R, Majori G, Nicoletti L, Rezza G, Cassone A. Angelini R, et al. Euro Surveill. 2007 Sep 6;12(9):E070906.1. doi: 10.2807/esw.12.36.03260-en. Euro Surveill. 2007. PMID: 17900424 No abstract available.
Chikungunya in north-eastern Italy: a summing up of the outbreak.
Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Silvi G, Macini P, Fortuna C, Venturi G, Magurano F, Fiorentini C, Marchi A, Benedetti E, Bucci P, Boros S, Romi R, Majori G, Ciufolini MG, Nicoletti L, Rezza G, Cassone A. Angelini R, et al. Euro Surveill. 2007 Nov 22;12(11):E071122.2. doi: 10.2807/esw.12.47.03313-en. Euro Surveill. 2007. PMID: 18053561 Review. No abstract available.
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.
De Bernardis F, Liu H, O'Mahony R, La Valle R, Bartollino S, Sandini S, Grant S, Brewis N, Tomlinson I, Basset RC, Holton J, Roitt IM, Cassone A. De Bernardis F, et al. J Infect Dis. 2007 Jan 1;195(1):149-57. doi: 10.1086/509891. Epub 2006 Nov 20. J Infect Dis. 2007. PMID: 17152019
367 results
Jump to page
Feedback